Zobrazeno 1 - 3
of 3
pro vyhledávání: '"S. M. Carrillo Vazquez"'
Autor:
D. X. Xibille Friedmann, S. M. Carrillo Vazquez, J. González Christen, D. Vega Morales, M. Garza Elizondo, R. Hernández, J. E. Ortíz Panozo, J. L. Montiel Hernández
Publikováno v:
Annals of the Rheumatic Diseases. 81:391-392
BackgroundA significant percentage of rheumatoid arthritis (RA) patients undergoing Infliximab (IFX) or Adalimumab (ADA) treatment develop antidrug antibodies with potential negative effects over their clinical activity; however, it is unknown if the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65620ec506fc907ffedd289d05c808e3
https://doi.org/10.1136/annrheumdis-2022-eular.2365
https://doi.org/10.1136/annrheumdis-2022-eular.2365
Publikováno v:
Annals of the Rheumatic Diseases. 80:899.3-900
Background:SARS-CoV2 infection and COVID-19 associated pneumonia are associated to a dysregulated inflammatory response known as cytokine storm and the use of cytokine inhibitors, especially those targeting IL-6, has been proposed as a therapeutic al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bc9d1782f7f706fa484d20e1b2b11fd
https://doi.org/10.1136/annrheumdis-2021-eular.3122
https://doi.org/10.1136/annrheumdis-2021-eular.3122
Publikováno v:
Arthritis & Rheumatology; Sep2018 Supplement S9, Vol. 70, p1-3553, 3553p